BD Announces Launch of Advanced Intelligent Targeted Temperature Management System – Arctic Sun 5000

China Economic Net, June 28 (Reporter Guowang Zhu) -- On June 26, the 24th China Emergency Medicine Academic Annual Conference with the theme of "Major Emergency, Major Rescue, Major Platform" was held in Changsha. On the occasion of the annual conference, BD Medical officially announced the launch of an advanced intelligent Target Temperature Management system -- the Stellar Arctic Sun 5000 Target Temperature Management System, which is dedicated to assisting clinicians in meeting the high-quality therapeutic needs of target temperature management to achieve the goal of effectively protecting patients' brains. The launch of this system also marks that Target Temperature Management Therapy (TTM) has entered a new phase of precise temperature control, intelligent efficiency, and safe non-invasiveness.

Professor Li Chunsheng from Beijing Friendship Hospital, Capital Medical University, Professor Lü Chuanzhu from Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Professor Zhang Guoqiang from China-Japan Friendship Hospital, Professor Zhu Yimin from Hunan Emergency Medicine Research Institute, Professor Zhang Mao from the Second Affiliated Hospital of Zhejiang University School of Medicine, Professor Tang Ziren from Beijing Chaoyang Hospital, Capital Medical University, Professor Hu Bei from Guangdong Provincial People's Hospital, and many other experts and scholars participated in this event. They shared and discussed the current development status, cutting-edge trends, and hot topics of Targeted Temperature Management (TTM) therapy both in China and internationally, and explored ways to further promote the standardization of the application of this therapy.

Globally, diseases such as cardiac arrest, traumatic brain injury, neonatal hypoxic-ischemic encephalopathy, and stroke face significant challenges in treatment and poor prognosis due to nerve damage, imposing enormous economic and social burdens on both patients and society. Taking cardiac arrest as an example, brain tissue is the most sensitive to ischemia and hypoxia; severe or even irreversible brain damage can occur 4 to 6 minutes after cardiac arrest. Ultimately, patients often suffer from serious neurological deficits, potentially leading to disability or death.

Target Temperature Management Therapy: An Effective but Technically Demanding Intervention

Professor Li Chunsheng emphasized: "China has a very mature foundation in emergency rescue fields such as cardiopulmonary resuscitation, which can provide patients with strong basic life support. However, there is an urgent need for improvement in the field of advanced life support, in which brain protection is particularly important. As an effective therapy for brain protection, targeted temperature management therapy is widely used internationally and has become a routine and standard treatment, especially giving us a glimpse of hope in solving the issue of disability after successful patient rescue. The implementation of targeted temperature management after cardiac arrest started relatively late in China, and clinical doctors have insufficient understanding of it, resulting in its still very limited use in China. Therefore, on one hand, we need to promote the clinical application of this therapy to address the practical problems of patients; on the other hand, we should focus on the hot spots and difficulties of this emerging therapy, actively carry out scientific research work, and elevate the level of post-cardiac arrest brain protection treatment to new heights."

Fortunately, China's targeted temperature management (TTM) therapy is gradually entering the fast lane of development. According to Li Chunsheng, the China Emergency Targeted Temperature Management Project Collaboration Group has been established, creating a nationwide academic exchange platform, promoting TTM skills, enhancing comprehensive TTM rescue capabilities, and better serving emergency physicians and patients across China.

Previously, the commonly used clinical cooling methods were limited to ice caps, ice blankets, etc. However, these methods cannot be equated with Targeted Temperature Management (TTM) and only serve as auxiliary means for rapid cooling. This is because these methods cannot reduce body temperature to the desired target range, lack an intelligent feedback system, cannot maintain a constant temperature, and are unable to rewarm slowly. Although intravascular cooling methods have similar therapeutic effects, they are invasive procedures with risks of postoperative thrombosis and infection. Moreover, the substantial infusion of fluids into patients also increases the risk of heart failure and pulmonary edema. These treatment methods fail to meet the requirements of targeted temperature management therapy, and there is an urgent need in clinical practice for better treatment options.

According to the introduction, the Ji Yao Arctic Sun 5000 Target Temperature Management System provides a full range of TTM solutions, including the Temperature Management System medical temperature control device and ArcticGel Pads medical cooling blankets. Yao Jiawei, head of Becton Dickinson's Greater China Urology and Critical Care business division, stated that he hopes it will help promote target temperature management therapy, allowing more clinical experts to see the benefits it brings to patients.